Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Breast Cancer Facts and Figures 2003 (American Cancer Society) at http://www.cancer.org/downloads/STT/CAFF2003BrFPWSecured.pdf
Silliman RA, Balducci L, Goodwin JS, Holmes FF, Leventhal EA. Breast cancer care in old age: what we know, don’t know, and do. J Natl Cancer Inst 1993: 85:190–199
Trimble EL, Carter CL, Cain D, Freidlin B, Ungerleider RS, Friedman MA. Representation of older patients in cancer treatment trials. Cancer 1994: 74(Suppl):2208–2214
Gazet JC, Markopoulos C, Ford HT, Coombes RC, Bland JM, Dixon RC. Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer. Lancet 1988: I:679–681
Morrow M, White J, Moughan J, Owen J, Pajak T, Sylvester J, et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol 2001: 19:2254–2262
Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med 1992: 326:1097–1101
Lazovich D, White E, Thomas DB, et al. Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA 1991: 226:3433–3438
Busch E, Kemeny M, Fremgen A, et al. Patterns of breast cancer care in the elderly. Cancer 1996: 78:101–111
Ballard-Barbash R, Potosky AL, Harlan LC, Nayfield SG, Kessler LG. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 1996: 88:716–726
Wanebo HJ, Cole B, Chung M, Vezeridis M, Schepps B, Fulton J, et al. Is surgical management compromised in elderly patients with breast cancer? Ann Surg 1997: 225:579–589
Yancik R, Wesley MN, Ries LAG, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 2001: 285:885–892
National vital statistics reports volume 51 #3 Dec. 19 2002. Life Expectancy national center for health statistics US department of health and human services centers for disease control and prevention, Table 11
Satariano, WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994: 120:104–110
Extermann M. Measuring comorbidity in older cancer patients. Eur J Cancer 200: 36:453–471
Diab SG, Elledgr RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 2000: 92:550–556
Clark GM, Osborne CK, McGuire WL. Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. J Clin Oncol 1984: 2:1102–1109
Wenger CR, Beardslee S, Owens MA, Pounds G, Oldaker T, Vendely P, et al. DNA ploidy, S-phase, and steroid receptors in more than 127 000 breast cancer patients. Breast Cancer Res Treat 1993: 28:9–20
Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, Lipa M, Wilkinson RH, Mahoney LJ. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 1996: 88:1659–1664
Liljegren L, Holmberg J, Bergh A, Lindgren L, Tabar L, Nordgren H, Adami HO, and the Uppsala-Orebro Breast Cancer Study Group. 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Clin Oncol 1999: 17:2326–2333
Fisher ER, Anderson S, Tan-Chiu E, Fisher B, Eaton L, Wolmark N. Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06. Cancer 2001 Apr 15: 91(8 Suppl):1679–1687
Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, Barillot I, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001: 345(19):1378–1387
Whelan T, Mackenzie R, Julian J, Levine M, Shelley W, Grimard L, et al. Randomized trial of breast irradiation schedules after lumpectomy with lymph node-negative breast cancer. J Natl Cancer Inst 2002: 94:1143–1150
Carter, KJ, Ritchey NP, Castro F, Caccamo LP, Kessler E, Erickson BA, Gawdyda, LM. Treatment of early-stage breast cancer in the elderly: A health-outcome-based approach. Med Decis Making 1998: 18:213–219
Punglia RS, Kuntz KM, Lee JH, Recht A. Radiation therapy plus tamoxifen versus tamoxifen alone after breast-conserving surgery in postmenopausal women with stage I breast cancer: a decision analysis. J Clin Oncol 2003: 21:2260–2267
Palda VA, Llewellyn-Thomas HA, Makenzie RG, Pritchard, KI, Naylor CD. Breast cancer patients’ attitudes about rationing postlumpectomy radiation therapy: Applicability of trade-off methods to policy-making. J Clin Oncol 1997: 15:3192–3200
Whelan TJ, Levine MN, Gafni A, Lukka H, Mohide EA, Patel M, Streiner DL. Breast irradiation post-lumpectomy: development and evaluation of a decision instrument. J Clin Oncol 1995: 13:847–853
Whelan T, Levine M, Gafni A, Sanders K, Willan A, Mirsky D, Schnider D, McCready D, Reid S, Kobylecky A, Reed K. Mastectomy or lumpectomy? Helping women make informed choices. J Clin Oncol 1999: 17:1727–1735
Whelan TJ, Sawka C, Levine M, Gafni A, Reyno L, Willan A, Julian J, Dent S, Abu-Zahra H, Chouinard E, Tozer R, Pritchard K, Bodendorfer I. Helping patients make informed choices: A randomized trial of a decision aid for adjuvant chemotherapy in lymph nodenegative breast cancer. J Natl Cancer Inst 2003: 95:581–587
Degner LF, Kristjanson LJ, Bowman D, Sloan JA, Carriere KC, O’Neil J, Bilodeau B, Watson P, Mueller B. Information needs and decisional preferences in women with breast cancer. JAMA. 1997: 277(18):1485–1492
Petrisek AC, Laliberte LL, Allen SM, Mor V. The treatment decision-making process: age differences in a sample of women recently diagnosed with nonrecurrent, early-stage breast cancer. Gerontologist 1997: 37:598–608
Sandison AJP, Gold DM, Wright P, Jones PA. Breast conservation or mastectomy: treatment choice of women aged 70 years and older. Br J Surg 1996: 83:994–996
Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002: 347:1233–1241
Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002: 347:1227–1232
Sarrazin D, Le MG, Arriagada R, et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 1989: 14:177–184
Blichert-Toft RC, Andersen JA, Overgaard M, Axelsson CK, Andersen KW, Mouridsen HT. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. J Natl Cancer Inst Monogr 1992: 11:19–25
van Dongen JA, Bartelink H, Fentiman IS, et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 Trial. J Natl Cancer Inst Monogr 1992: 11:15–18
Lichter AS, Lippman ME, Danforth JR, et al. Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute. J Clin Oncol 1992: 10:976–983
Early Breast Cancer Trialists’ Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 2000: 355:1757–1770
Morris AD, Morris RD, Willson JF, et al. Breast-conserving therapy vs. mastectomy in early-stage breast cancer: a meta-analysis of 10 year survival. Cancer J Sci Am 1997: 3:6–12
Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 2001: 12:997–1003
Forest AP, Stewart HJ, Everington D, Prescott RJ, McArdle CS, Harnett AN. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Lancet 1996: 348:708–713
Holli K, Saaristo R, Isola J, Joensuu H, Hakama M. Lumpectomy with or without postoperative radiotherapy of breast cancer with favourable prognostic features: results of a randomized study. Br J Cancer 2001: 84(2):164–169
Fisher B, Bryant J, Dignam JJ, Wickerham DL, Mamounas EP, Fisher ER, et al. Tamoxifen, radiation therapy or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 2002: 20:4141–4149
Fyles A, McCready D, Manchul L, Trudeau M, Olivotto I, Merante P, et al. Preliminary results of a randomized study of tamoxifen +/− breast radiation in T1/2 NO disease in women over 50 years of age. Proc Am Soc Clin Oncol 2001: 20:24a, (abstr 92)
Hughes KS, Schnaper L, Berry D, Cirrincione C, McCormick B, Shank B, et al. Comparison of lumpectomy plus tamoxifen with and without radiotherapy (RT) in women 70 years of age or older who have clinical stage 1, estrogen receptor positive (EP+) breast carcinoma [abstract]. Proc Am Soc Clin Oncol 2001: 20:24a
Wyckoff J, Greenberg H, Sanderson R, Wallach P, Balducci L. Breast irradiation in the older woman: a toxicity study. J Am Geriatr Society 1994: 42:150–152
Santiago RJ, Wu L, Harris E, Fox K, Schultz D, Glick J, Solin LJ. Fifteen-year results of breast-conserving surgery and definitive irradiation for stage I and II breast cancer: The University of Pennsylvania experience. Int J Radiat Oncolo Biol Phys 2004: 58:233–2404
Urtishak SL, Harris EE, Hwang W-T, Solin LJ. Ten-year outcomes for elderly women treated with breast-conserving surgery and definitive breast irradiation for early stage breast cancer [abstract]. Proc Am Soc Clin Oncol 2003: 22:11
Zachariah B, Balducci L, Venkattaramanabalaji GV, Casey L, Greenberg HM, Del Regato JA. Radiotherapy for cancer patients aged 80 and older: a study of effectiveness and side effects. Int J Radiat Oncol Biol Phys 1997: 39:1125–1129
Wasil T, Lichtman SM, Gupta V, Rush S. Radiation therapy in cancer patients 80 years of age and older. Am J Clin Oncol 2000: 23:526–530
Deutsch M. Radiotherapy after lumpectomy for breast cancer in very old women. Am J Clin Oncol 2002: 25:48–49
Kunkler H, King CC, Williams IJ, Prescott RJ, Jack W. What is the evidence for a reduced risk of local recurrence with age among older patients treated by breast conserving therapy? Breast 2001: 10:464–469
Nattinger AB, Hoffmann RG, Kneusel RT, Schapira MM. Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery. Lancet 2000: 356:1148–1153
Lazovich D, Solomon CC, Thomas DB, Moe RE, White E. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer 1999: 86:628–637
Romestaing P, Lehingue Y, Carrie C, Coquard R, Montbarbon X, Ardiet JM, et al. Role of 10 Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol 1997: 15(3):677–685
Teissier E, Hery M, Ramaioli A, Lagrange JL, Curdi A, Bensadoun RJ, et al. Boost in conservative treatment: 6 years results of randomized trial [abstract]. Breast Cancer Res Treat 1998: 50:287
Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot JC, Jager JJ, et al. On behalf of the EORTC Radiotherapy and Breast Cancer Cooperative Groups. The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC “boost versus no boost” trial. Int J Radiat Oncol Biol Phys 1999: 45(3):677–685
Bartelink H. Radiotherapy to the conserved breast, chest wall, and regional nodes: is there a standard? Breast 2003: 12:475–482
Whelan TJ, Levine M, Julian J, Kirkbride P, Skingley P. The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomised trial. Ontario Clinical Oncology Group. Cancer 2000: 88:2260–2266
Yarnold J, Owen R, Ashton A, Broad B, Regan J, Bliss J, et al. Fractionation sensitivity of change in breast appearance after radiotherapy for early breast cancer: results of a phase III randomized trial. Breast Cancer Res Treat 2001: 69:230
Baillet F, Housset M, Maylin C, Boisserie G, Battahar R, Delanian S, et al. The use of a specific hypofractionated radiation therapy regimen versus classical fractionation in the treatment of breast cancer: a randomized study of 230 patients. Int J Radiat Oncol Biol Phys. 1990: 19:1131–1133
Whelan TJ. Radiation therapy for early breast cancer 2004: Radiotherapy parameters-fractionation, total dose, and nodal treatment [abstract]. Proc Am Soc Clin Oncol 2004
Hannoun-Levi JM, Courdi A, Marsiglia H, Namer M, Gerard JP. Breast cancer in elderly women: is partial breast irradiation a good alternative? Breast Cancer Res Treat 2003: 81:243–251
Ribeiro GG, Magee B, Swindell R, Harris M, Banerjee SS. The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol (R Coll Radiol) 1993: 5(5):278–283
Vaidya JS, Baum M, Tobias JS, Morgan S, D’Souza D. The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer. Eur J Surg Oncol 2002: 28(4):447–454
Veronesi U, Gatti G, Luini A, Intra M, Ciocca M, Sanchez D, Zurrida S, Navarro S, Orecchia R. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Arch Surg 2003: 138:1253–1256
King TA, Bolton JS, Kuske RR, Fuhrman GM, Scoggins TG, Jiang XZ. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg 2000: 180:299–304
Keisch M, Vicini F, Kuske RR, Hebert M, White J, Quiet C, Arthur D, Scroggins T, Streeter O. Initial clinical experience with the MammoSite brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2003: 55:289–293
Vicini FA, Remouchamps V, Wallace M, Sharpe M, Fayad J, Tyburski L, Letts N, Kestin L, Edmundson G, Pettinga J, Goldstein NS, Wong J. Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2003: 57:1247–1253
Vicini FA, Kestin L, Chen P, Benitez P, Goldstein NS, Martinez A. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 2003: 95(16):1205–1210
Polgar C, Sulyok Z, Fodor J, Orosz Z, Major T, Takacsi-Nagy Z, Mangel L, Somogyi A, Kasler M, Nemeth G. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol 2002: 80:121–128
Whelan T, Olivotto I, Levine M, for the steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: 6. Radiotherapy after breast-conserving surgery (Summary of the 2003 update). CMAJ 2003: 168:437–439
Bentzen SM, Skoczylas JZ, Overgaard M, Overgaard J. Radiotherapy-related lung fibrosis enhanced by tamoxifen. J Natl Cancer Inst 1996: 88:918–922
Wazer DE, DiPetrillo T, Schmidt-Ullrich R, Weld L, Smith TJ, Marchant DJ, et al. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 1992: 10:356–363
Harris EER, Christensen VJ, Hwang WT, Fox K, Solin LJ. The impact of concurrent versus sequential tamoxifen and radiation therapy in breast cancer patients undergoing breast conservation treatment. J Clin Oncol 2005: 23:11–16
Pierce LJ, Hutchins L, Green SJ, Lew D, Gralow J, Livingston RB, Osborne K, Albain KS, for the Southwest Oncology Group. Sequencing of tamoxifen (TAM) and radiotherapy (RT) with breast conservation (BCT) in early stage breast cancer [abstract]. Proc Am Soc Clin Oncol 2003: 22:10
Recht A, Edge SB, Solin LJ, Robinson DS, Estabrook A, Fine RE, Fleming GF, Formenti S, Hudis C, Kirshner JJ, Krause DA, Kuske RR, Langer AS, Sledge GW, Whelan TJ, Pfister DG. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001: 19:1539–1569
Truong PT, Olivotto IA, Whelan TJ, Levine M, for the Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: Post-mastectomy locoregional radiotherapy. CMAJ 2004: 170:1263–1273
Ragaz J, Jackson SM, Le N, Plenderleith I, Spinelli J, Basco V, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997: 337:956–962
Overgaard M, Hansen P, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997: 337:949–955
Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish breast cancer cooperative group DBCG 82c randomized trial. Lancet 1999: 353:1641–1648
Whelan TJ, Julian J, Wright J, Jadad AR, Levine ML. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 2000: 18:1220–1229
Katz A, Strom EA, Buchholz TA, Thames HD, Smith CD, Jhingran A, Hortobagyi G, Buzdar AU, Theriault R, Singletary SE, McNeese MD. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 2000: 18(15):2817–2827
Cuzick J, Stewart H, Rutqvist L, Houghton J, Edwards R, Redmond C, Peto R, Baum M, Fisher B, Host H, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994: 12(3):447–453
Hojris I, Overgaard M, Christensen JJ, Overgaard J. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group. Lancet 1999 Oct 23: 354(9188):1425–1430
Arriagada R, Mouriesse H, Sarrazin D, Clark RM, Deboer G. Radiotherapy alone in breast cancer. I. Analysis of tumor parameters, tumor dose and local control. Int J Radiat Oncol Biol Phys 1985: 11:1751–1757
Wu JS, Wong R, Johnston M, Bezjak A, Whelan T. Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 2003: 55(3):594–605
Priestman TJ, Dunn J, Brada M, Rampling R, Baker PG. Final results of the Royal College of Radiologists trial comparing two different radiotherapy schedules in the treatment of cerebral metastases. Clin Oncol (R Coll Radiol) 1996: 8(5):308–15
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Whelan, T. (2006). The Elderly and Breast Cancer Radiotherapy. In: Piccart, M.J., Hung, MC., Solin, L.J., Cardoso, F., Wood, W.C. (eds) Breast Cancer and Molecular Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-28266-2_15
Download citation
DOI: https://doi.org/10.1007/978-3-540-28266-2_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-28265-5
Online ISBN: 978-3-540-28266-2
eBook Packages: MedicineMedicine (R0)